Dr. Reddy’s Laboratories (RDY) and Coya Therapeutics (COYA) are collaborating on an ALS treatment. CEO of RDY Marc Kikuchi and CEO of COYA Howard Berman join Oliver Renick to discuss this collaboration. They talk about the timeline for approval of COYA’s ALS therapy. RDY and COYA intend to begin the Coya 302 Trial in 2Q 2024. Tune in to find out more about the stock market today.
Morning Trade Live
29 Feb 2024
SHARE
The Watch List
05 Mar 2024
Market On Close
20 Mar 2024
Morning Trade Live
15 Apr 2024
Market On Close
06 Mar 2024
Morning Trade Live
03 May 2024
Morning Trade Live
07 Mar 2024